Injective INJ
Current Price
$3.86 +3.55%
$0.1900 Daily Range (4.92%)
$3.70$3.89
$70.93M Daily Volume
872 BTC
Vol/MktCap: 18.34%
Market Performance
0.18% Relative BTC Volume
The total volume of Injective is $70.93M over the past 24 hours, compared to $40.29B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.83 +0.83%
13 SMA $3.81 +1.32%
21 SMA $3.79 +1.73%
55 SMA $3.75 +2.89%
144 SMA $3.69 +4.69%
Price Performance
-0.28% 1 Hour Change
$3.86 from $3.87
+6.69% 7 Day Change
$0.2583 from $3.60
+15.46% 14 Day Change
$0.5969 from $3.26
+34.75% 30 Day Change
$1.34 from $2.52
All Time High
March 14, 2024
$52.62 -92.66%
-$48.76 vs. now
24H Change
13.22M USD +3.54%
162 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
18.69M INJ
traded over past 24 hours
18.69% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.76, reflecting a 1.73% increase over the past 24 hours, with a trading range between $3.68 and $3.85. The volume of 61,369,434 indicates a significant level of trading activity, as evidenced by a volume-to-market cap ratio of 16.33%.
The moving averages are showing mixed signals; the 8 and 13 SMA are indicating slight downtrends at -0.44% and -0.46%, while the longer-term 21 SMA is slightly positive at +0.15%, suggesting short-term weakness but potential recovery in longer time frames. The 55 SMA has a more robust upward movement at +0.51%, and the 144 SMA is indicating a strong bullish trend with a +2.44% increase, reflecting a more positive outlook for the asset over the longer term.
The RSI metrics show a current 1-hour RSI of 49, indicating neutrality and potential indecision in the short term. However, the 7-day RSI at 56 suggests a mild bullish sentiment, reinforced by a notable price increase of 5.38% over the past week, 15.20% over the last 14 days, and a substantial 34.62% over the past 30 days, indicating strong bullish momentum.
Given the current price action, technical indicators, and the overall bullish trends in longer time frames, Injective appears to be consolidating above support levels. The current trading activity and RSI metrics suggest potential upward movement; however, traders should remain cautious due to the mixed short-term moving averages.
Based on this analysis, the recommendation for Injective (INJ) is a Buy. The overall upward trend in the 30-day price change, coupled with positive long-term moving averages, indicates a favorable market condition for entering a position.
The moving averages are showing mixed signals; the 8 and 13 SMA are indicating slight downtrends at -0.44% and -0.46%, while the longer-term 21 SMA is slightly positive at +0.15%, suggesting short-term weakness but potential recovery in longer time frames. The 55 SMA has a more robust upward movement at +0.51%, and the 144 SMA is indicating a strong bullish trend with a +2.44% increase, reflecting a more positive outlook for the asset over the longer term.
The RSI metrics show a current 1-hour RSI of 49, indicating neutrality and potential indecision in the short term. However, the 7-day RSI at 56 suggests a mild bullish sentiment, reinforced by a notable price increase of 5.38% over the past week, 15.20% over the last 14 days, and a substantial 34.62% over the past 30 days, indicating strong bullish momentum.
Given the current price action, technical indicators, and the overall bullish trends in longer time frames, Injective appears to be consolidating above support levels. The current trading activity and RSI metrics suggest potential upward movement; however, traders should remain cautious due to the mixed short-term moving averages.
Based on this analysis, the recommendation for Injective (INJ) is a Buy. The overall upward trend in the 30-day price change, coupled with positive long-term moving averages, indicates a favorable market condition for entering a position.
Updated 434 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin vs Ethereum – How April’s recovery exposes market divide between them
After March's setback, April was strong, but supply and demand patterns have been different.

Bitcoin holds $81K amid flat derivatives markets: Is rally sustainable?
Bitcoin carved a path toward $82,000, but derivatives metrics need another push from bulls to sustain the rally.

Israel bombs 21 Lebanese villages amid ceasefire, raising withdrawal concerns
Heightened military tensions may delay Israel's withdrawal, impacting regional stability and altering geopolitical dynamics in the Middle East.

Ukraine boosts defenses with Palantir AI amid Russian conflict
Ukraine's integration of AI in military operations may shift the conflict dynamics, potentially reducing Russian advances and altering strategic dependencies.